ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET

Al Kildani - Senior Vice President, Investor Relations and Corporate Communications
Steve Davis - President and Chief Executive Officer
Brendan Teehan - Chief Operating Officer, Head of Commercial
Kimberly Manhard - Senior Vice President, Global Strategic Planning and Execution
Mark Schneyer - Chief Financial Officer
Parag Meswani - Senior Vice President, Trofinetide
Elizabeth Thompson - Executive Vice President, Head of Research and Development

Ritu Baral - TD Cowen
Charles Duncan - Cantor
Anish Nikhanj - RBC Capital Markets
Joel Beatty - Baird …